|
Carol Baum, MBA, Vice President Marketing oversees all commercial operations functions. Carol Baum joined Neurocrine in 2003 as a member of the Marketing Team and has most recently been responsible for development and implementation of the commercialization strategy for Indiplon. Prior to joining Neurocrine, Carol was a Director of Marketing at Aventis Pharmaceuticals and has previous commercial experience in both primary care and specialty markets as well as a background in new product planning. Carol graduated from the University of Colorado with high honors and received her MBA from Webster University. Carol also received certification from the UCLA Anderson School of Management / Medical Marketing Association and has been acknowledged in Medical Marketing and Media. | 